Neovasc Inc. to participate in Lazard Capital Markets Annual Medical Technology and Life Sciences/Tools Snowbird Conference
/FROM PR NEWSWIRE DALLAS 888-776-3971/ STK TorontoVE:NVC IN MTC SU TDS TO BUSINESS EDITORS: Neovasc Inc. to participate in Lazard Capital Markets Annual Medical Technology and Life Sciences/Tools Snowbird Conference TSX Venture Exchange: NVC VANCOUVER, Feb. 22, 2012 /PRNewswire/ - Neovasc Inc.(TSXV: NVC), a developer of novel technologies used to treat vascular disease, today announced that the company will participate in the Lazard Capital Markets Annual Medical Technology and Life Sciences/Tools Snowbird Conference. The event is being held at the Snowbird Resort in Snowbird, UTFebruary 29-March 2, 2012.
The conference format consists of one-on-one meetings between participating companies and institutional investors. Investors interested in meeting with Neovasc should contact Lazard Capital Markets directly.
About Neovasc Inc. Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc ReducerT for the treatment of refractory angina, the TiaraT technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
-0- 02/22/2012 /CONTACT: <p> <i><b>Corporate contact: </b></i><br/> Neovasc Inc.<br/> Chris Clark<br/> 604 248-4138<br/> <br/> <i><b>U.S. media & investor contact:</b></i><br/> GendeLLindheim BioCom Partners<br/> Barbara Lindheim<br/> 212 584-2276, ext. 201<br/> email@example.com </p> (TorontoVE:NVC) / CO: Neovasc Inc.
ST: British Columbia IN: MTC SU: TDS PRN -- TO952 -- 0000 02/22/2012 12:28:00 EDT http://www.prnewswire.c